These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24266804)

  • 1. New drugs in sarcomas.
    Martin-Liberal J; Benson C; Judson I
    Expert Opin Pharmacother; 2014 Feb; 15(2):221-9. PubMed ID: 24266804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pazopanib in the treatment of soft tissue sarcoma.
    Schöffski P
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):711-23. PubMed ID: 22716487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas.
    Mohindra N; Agulnik M
    Expert Opin Investig Drugs; 2015; 24(11):1409-18. PubMed ID: 26289790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.
    Vincenzi B; Napolitano A; D'Onofrio L; Frezza AM; Silletta M; Venditti O; Santini D; Tonini G
    Expert Opin Investig Drugs; 2011 Dec; 20(12):1685-705. PubMed ID: 22010859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the approach to novel drug clinical development for breast cancer.
    Ferrario C; Batist G
    Expert Opin Drug Discov; 2014 Jun; 9(6):647-68. PubMed ID: 24758225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
    Martin-Liberal J; Pérez E; García Del Muro X
    Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies in soft tissue sarcoma.
    Vincenzi B; Frezza AM; Santini D; Tonini G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for MEK inhibitors for treating cancer.
    Martin-Liberal J; Lagares-Tena L; Larkin J
    Expert Opin Drug Saf; 2014 Apr; 13(4):483-95. PubMed ID: 24597490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer medical therapies for metastatic soft tissue sarcoma.
    Tiwari A; Gupta VG; Bakhshi S
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):257-270. PubMed ID: 28103739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
    Riedel RF
    Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapies for Liposarcoma.
    Saponara M; Stacchiotti S; Gronchi A
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):361-377. PubMed ID: 28135854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib, a new therapy for metastatic soft tissue sarcoma.
    Verweij J; Sleijfer S
    Expert Opin Pharmacother; 2013 May; 14(7):929-35. PubMed ID: 23488774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management options for liposarcoma and challenges for the future.
    Kollár A; Benson C
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):297-306. PubMed ID: 24397249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.
    Chmielowski B; Federman N; Tap WD
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1217-28. PubMed ID: 23098121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting insulin-like growth factor 1 receptor in sarcomas.
    Scotlandi K; Picci P
    Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Role of Novel Agents in the Treatment of Soft Tissue Sarcoma].
    Naito Y
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):463-467. PubMed ID: 28698434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies.
    Yap TA; Olmos D; Molife LR; de Bono JS
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1293-304. PubMed ID: 21777167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.